M&As this week: Beijing Beilu Pharmaceutical, Advance Medical Systems


In a $14.38m deal, Beijing Beilu Pharmaceutical has signed an agreement to acquire approximately 5.43 million shares, representing 15% stake in a company based in Wuhan, Hubei, China.

The closing of the transaction will bring Beijing Beilu’s total stake in the firm to 25%.

Digital health solutions provider mySugr GmbH has been purchased by Roche Pharmaceutical company from iSeed Ventures, a venture capital firm.

The acquisition will make mySugr an integral part of the acquirer’s new diabetes care digital health services platform, which offers diabetes devices and services for its global customer base.

"The transaction will enable mySugr’s international growth, while enabling Roche to expand its position in diabetes management."

The transaction will enable mySugr’s international growth, while enabling Roche to expand its position in diabetes management.

Advance Medical Systems will be acquired by Yantai Dongcheng Biochemicals through a cash and share issue transaction.

At the same time, the acquirer intends to raise gross proceeds of $10.95m in a private placement of shares.